PT1512004E - Metodo para mapear e eliminar epitopos para celulas t - Google Patents

Metodo para mapear e eliminar epitopos para celulas t

Info

Publication number
PT1512004E
PT1512004E PT03740219T PT03740219T PT1512004E PT 1512004 E PT1512004 E PT 1512004E PT 03740219 T PT03740219 T PT 03740219T PT 03740219 T PT03740219 T PT 03740219T PT 1512004 E PT1512004 E PT 1512004E
Authority
PT
Portugal
Prior art keywords
cells
epitopes
identification
epithopes
mapping
Prior art date
Application number
PT03740219T
Other languages
English (en)
Inventor
Baker Matthew
Francis J Carr
Carter Graham
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1512004(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1512004E publication Critical patent/PT1512004E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
PT03740219T 2002-06-11 2003-06-11 Metodo para mapear e eliminar epitopos para celulas t PT1512004E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012919 2002-06-11

Publications (1)

Publication Number Publication Date
PT1512004E true PT1512004E (pt) 2006-08-31

Family

ID=29724386

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03740219T PT1512004E (pt) 2002-06-11 2003-06-11 Metodo para mapear e eliminar epitopos para celulas t

Country Status (16)

Country Link
EP (1) EP1512004B1 (pt)
JP (1) JP2005529170A (pt)
CN (1) CN100401064C (pt)
AT (1) ATE320603T1 (pt)
AU (1) AU2003273679A1 (pt)
BR (1) BR0311720A (pt)
CA (1) CA2489180A1 (pt)
DE (1) DE60304040T2 (pt)
DK (1) DK1512004T3 (pt)
ES (1) ES2257680T3 (pt)
MX (1) MXPA04012209A (pt)
PL (1) PL371675A1 (pt)
PT (1) PT1512004E (pt)
RU (1) RU2334235C2 (pt)
WO (1) WO2003104803A2 (pt)
ZA (1) ZA200500214B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL376673A1 (pl) * 2003-02-18 2006-01-09 Merck Patent Gmbh Białka fuzyjne mutein interferonu alfa o ulepszonych właściwościach
US7339031B2 (en) 2004-03-19 2008-03-04 Merck Patent Gmbh Modified bouganin proteins, cytotoxins and methods and uses thereof
FR2940451B1 (fr) 2008-12-18 2014-09-12 Proteus Procede d'evaluation de l'immunogenicite des proteines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
US5945401A (en) * 1995-06-23 1999-08-31 Conlon; Paul J. Peptide analogues of the 65KD isoform of human glutamic acid decarboxylase and uses thereof
US6165460A (en) * 1995-07-10 2000-12-26 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (PSA)
DE69733343D1 (de) * 1996-03-21 2005-06-30 Circassia Ltd Kryptische peptide und verfahren zu ihrer identifizierung
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
CN1202128C (zh) * 1998-12-08 2005-05-18 拜奥威神有限公司 修饰蛋白的免疫原性
EP1469721B1 (en) * 2000-10-02 2011-04-06 Danisco US Inc. Method of determining the immunogenicity of proteins producing an altered immunogenic response

Also Published As

Publication number Publication date
DE60304040D1 (de) 2006-05-11
MXPA04012209A (es) 2005-02-25
AU2003273679A1 (en) 2003-12-22
EP1512004A2 (en) 2005-03-09
RU2005100758A (ru) 2006-01-20
CN100401064C (zh) 2008-07-09
ATE320603T1 (de) 2006-04-15
JP2005529170A (ja) 2005-09-29
DE60304040T2 (de) 2006-09-28
RU2334235C2 (ru) 2008-09-20
ZA200500214B (en) 2006-02-22
CN1659437A (zh) 2005-08-24
DK1512004T3 (da) 2006-06-06
WO2003104803A2 (en) 2003-12-18
ES2257680T3 (es) 2006-08-01
EP1512004B1 (en) 2006-03-15
WO2003104803A3 (en) 2004-04-15
BR0311720A (pt) 2005-03-01
PL371675A1 (en) 2005-06-27
CA2489180A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
CY1110868T1 (el) Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
DK1699822T3 (da) IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
NO20054351L (no) Monoklonalt antistoff og hybridom som produserer dette
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
NO20014584D0 (no) Proteinisolering og -analyse
NO20063026L (no) Antistoffer
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
RS54127B1 (en) ANTIBODIES NEUTRALIZERS OF THE HUMAN FACTOR OF STIMULATION OF THE COLONIA OF THE GRANULLocyte MACROPHAGUS
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
TW200510459A (en) RG1 antibodies and uses thereof
DK1620456T3 (da) Hla-a2 tumor-associerede antigen-peptider og præparater
DE602004017864D1 (de) Trägerproteine für impfstoffe
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
ATE438662T1 (de) Verbesserte fc-fusionsproteine
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
ATE370745T1 (de) Verbesserte polysaccharid- und glykokonjugat- vakzine
ZA200500214B (en) Method for mapping and eliminating T-cell epitopes.
ATE316577T1 (de) Das goodpasture-antigen bindende protein
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
AU2174002A (en) Method for analyzing proteins
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
DE69840326D1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen